We are live on ! Find out more
GOSS icon

Gossamer Bio
GOSS

141 hedge funds and large institutions have $520M invested in Gossamer Bio in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 42 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

173% more call options, than puts

Call options by funds: $13M | Put options by funds: $4.76M

47% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 17

12% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 42

6% more funds holding

Funds holding: 133 → 141 (+8)

1.38% more ownership

Funds ownership: 76.92% → 78.3% (+1.4%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

22% less capital invested

Capital invested by funds: $664M → $520M (-$144M)

Holders
141
Holders Change
+8
Holders Change %
+6.02%
% of All Funds
2.22%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
25
Increased
47
Reduced
42
Closed
17
Calls
$13M
Puts
$4.76M
Net Calls
+$8.22M
Net Calls Change
+$9.69M

Top Buyers

Rank Fund Capital Flow
1
OCA
Octagon Capital Advisors
New York
+$10.1M
2
KCM
Kynam Capital Management
New Jersey
+$7.87M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$5.44M
4
EP
Eversept Partners
New York
+$3.23M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.59M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$7.72M
2
WP
Woodline Partners
California
-$6.5M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$4.41M
4
IC
Ikarian Capital
Texas
-$3.78M
5
PHP
Parkman Healthcare Partners
Connecticut
-$3.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
126
Aquatic Capital Management
Illinois
$10K +$11.6K +1,200 New
AW
127
Alaethes Wealth
Nevada
$7K +$7.23K +750 New
FDCDDQ
128
Federation des caisses Desjardins du Quebec
Quebec, Canada
$6.51K – – –
BHWM
129
Beaird Harris Wealth Management
Texas
$6K – – –
LC
130
Lindbrook Capital
California
$4K +$4.34K +450 New
CAPTRUST Financial Advisors
131
CAPTRUST Financial Advisors
North Carolina
$3K +$1.83K +190 +95%
Daiwa Securities Group
132
Daiwa Securities Group
Japan
$2K – – –
LWANC
133
Laurel Wealth Advisors (North Carolina)
North Carolina
$2K – – –
PP
134
PFS Partners
New Jersey
$1.46K -$39 -4 -2%
IRC
135
Investors Research Corp
Georgia
$1K – – –
SIC
136
Salem Investment Counselors
North Carolina
$1K – – –
PFS
137
Prospera Financial Services
Texas
$1K +$964 +100 New
Carson Wealth (CWM LLC)
138
Carson Wealth (CWM LLC)
Nebraska
$1K +$1.59K +165 New
Macquarie Group
139
Macquarie Group
Australia
$14 – – –
O
140
OrbiMed
New York
– -$7.72M -683,000 Closed
Lord, Abbett & Co
141
Lord, Abbett & Co
New Jersey
– -$4.41M -390,146 Closed
ACP
142
Acuta Capital Partners
California
– -$1.35M -119,843 Closed
MCM
143
Moore Capital Management
New York
– -$1.23M -109,024 Closed
Barclays
144
Barclays
United Kingdom
– -$819K -72,450 Closed
Ohio Public Employees Retirement System (OPERS)
145
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$795K -70,332 Closed
E
146
Ergoteles
New York
– -$456K -40,316 Closed
GTCM
147
Gyon Technologies Capital Management
New Jersey
– -$387K -34,222 Closed
Belvedere Trading
148
Belvedere Trading
Illinois
– -$145K -14,089 Closed
XT
149
XTX Topco
Cayman Islands
– -$151K -13,310 Closed
TYCC
150
Texas Yale Capital Corp
Florida
– -$113K -10,000 Closed
3 4 5
6
7

GOSS Hedge Fund Activity: Q1 2022 in Review

141 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q1 2022, worth a combined $520M — down 22% from $664M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new GOSS positions and 17 closed out — a net gain of 8 holders — while 47 added to existing stakes and 42 trimmed.

The largest buyer was Octagon Capital Advisors, adding an estimated $10.1M. The largest seller was OrbiMed, exiting entirely with an estimated $7.72M sold.

  • 141 institutional investors held Gossamer Bio (GOSS) as of Q1 2022, up from 133 in Q4 2021.
  • Funds reported $520M of Gossamer Bio stock for Q1 2022, down 22% quarter-over-quarter.
  • 25 funds opened new Gossamer Bio positions in Q1 2022 and 17 closed out, a net change of +8 holders.
  • The largest Gossamer Bio buyer in Q1 2022 was Octagon Capital Advisors, an estimated $10.1M added.
  • The largest Gossamer Bio seller in Q1 2022 was OrbiMed, an estimated $7.72M sold.

Based on aggregated 13F filings for Q1 2022.